Search
Close this search box.

Protein A Chromatography Multi-scale Mechanistic Modeling (Phase 1)

Develop a modeling infrastructure for simulating protein A chromatography performance in the manufacture of monoclonal antibodies. Objective is to describe and predict the values of routinely measured key outputs in process manufacturing applications.
Categories
Proteins/ Antibodies
Drug substance
Process control
Data
Project status
100% Completed

Industry Need

Laboratory experiments increase new product development cost

Solution

Use Protein A modeling to reduce laboratory experimentation

Outputs/Deliverables

  • Modelling Software in Open-Source platform (done)
  • Model Use Training documentation (done)

Impacts

Reduce process development time and cost of Antibody products.

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access more, including: 

  • Updates
  • Value Proposition
  • Related Publications
  • Deliverables

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute

Participating Organizations

AstraZeneca

AstraZeneca

Boehringer Ingelheim

Boehringer Ingelheim

Bristol-Myers Squibb

Bristol-Myers Squibb

Cytiva

Cytiva

Federal Stakeholder: National Institute of Standards and Technology

Federal Stakeholder: National Institute of Standards and Technology

Genentech, Inc.

Genentech, Inc.

Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC

MilliporeSigma/EMD Serono

MilliporeSigma/EMD Serono

NIIMBL

NIIMBL

Pfizer, Inc.

Pfizer, Inc.

Sanofi

Sanofi

University of Delaware

University of Delaware